Literature DB >> 2331190

Quinine hepatotoxicity. An underrecognized or rare phenomenon?

R C Punukollu1, S Kumar, K D Mullen.   

Abstract

Quinine-induced hepatic injury has been reported very rarely. We report a case involving a patient with an apparent hypersensitivity to quinine, manifested by a clinical syndrome mimicking a viral illness and a mixed hepatocellular-cholestatic liver injury pattern. We briefly review the unusual literature on this topic, which features many cases of hypersensitivity to the optical isomer of quinine, quinidine; yet, to our knowledge, there has only been one prior report of quinine hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331190     DOI: 10.1001/archinte.150.5.1112

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine.

Authors:  Ai Katsuma; Maki Shibata; Takashi Katsuki; Eri Imai; Manami Tada; Fumihiko Hinoshita
Journal:  CEN Case Rep       Date:  2014-08-29

2.  Probable quinine-induced hepatotoxicity.

Authors:  J A Perez; J Stryker; E L Arsura; J M Hewitt
Journal:  West J Med       Date:  1994-01

Review 3.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Artemether-lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in a Portuguese centre.

Authors:  André Silva-Pinto; Rogério Ruas; Francisco Almeida; Raquel Duro; André Silva; Cândida Abreu; António Sarmento
Journal:  Malar J       Date:  2017-01-25       Impact factor: 2.979

5.  The Impact of Malaria on Liver Enzymes: A Retrospective Cohort Study (2010-2017).

Authors:  James Cheaveau; Dewdunee Marasinghe; Samantha Akakpo; Rob Deardon; Christopher Naugler; Alex Chin; Dylan R Pillai
Journal:  Open Forum Infect Dis       Date:  2019-05-16       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.